Oocyte Donation
-
Subject Areas on Research
- A step toward solving some of the problems of cryopreservation.
- Age-related infertility.
- Anti-müllerian hormone (AMH) and repetitive oocyte donation.
- Do donor oocyte cycles comply with ASRM/SART embryo transfer guidelines? An analysis of 13,393 donor cycles from the SART registry.
- Donor oocytes are associated with preterm birth when compared to fresh autologous in vitro fertilization cycles in singleton pregnancies.
- Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient cycles: an analysis of 109,140 clinical pregnancies from the Society for Assisted Reproductive Technology registry.
- Oocyte donation.
- Outcomes of donor oocyte cycles in assisted reproduction.
- Pregnancy outcomes decline in recipients over age 44: an analysis of 27,959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology.
- Pregnancy outcomes decline with increasing recipient body mass index: an analysis of 22,317 fresh donor/recipient cycles from the 2008-2010 Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry.
- Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology.
- Prevalence of a Good Perinatal Outcome With Cryopreserved Compared With Fresh Donor Oocytes.
- Semen quality: is there a paternal effect on pregnancy outcome in in-vitro fertilization/intracytoplasmic sperm injection?
- The impact of an egg donor's age and her prior fertility on recipient pregnancy outcome.
- Third-party reproduction in the Internet Age: the new, patient-centered landscape.
- Total follicle stimulating hormone dose is negatively correlated with live births in a donor/recipient model with fresh transfer: an analysis of 8,627 cycles from the Society for Assisted Reproductive Technology Registry.
- Use of human gametes obtained from anonymous donors for the production of human embryonic stem cell lines.
- Using Society for Assisted Reproductive Technology data to track pregnancy outcomes in older recipients: is it justifiable?